CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · IEX Real-Time Price · USD
4.780
+0.030 (0.63%)
At close: Jul 26, 2024, 3:53 PM
4.570
-0.210 (-4.39%)
After-hours: Jul 26, 2024, 7:39 PM EDT

CollPlant Biotechnologies Revenue

CollPlant Biotechnologies had revenue of $98.00K in the quarter ending March 31, 2024, a decrease of -77.37%. This brings the company's revenue in the last twelve months to $10.62M, up 1,495.20% year-over-year. In the year 2023, CollPlant Biotechnologies had annual revenue of $10.96M with 3,565.22% growth.

Revenue (ttm)
$10.62M
Revenue Growth
+1,495.20%
P/S Ratio
5.15
Revenue / Employee
$141,653
Employees
75
Market Cap
54.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202310.96M10.66M3,565.22%
Dec 31, 2022299.00K-15.34M-98.09%
Dec 31, 202115.64M9.50M154.86%
Dec 31, 20206.14M3.82M164.75%
Dec 31, 20192.32M-2.70M-53.77%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rockwell Medical 86.62M
Neuronetics 73.23M
Allurion Technologies 48.78M
Cidara Therapeutics 46.38M
Cytosorbents 36.69M
MSP Recovery 9.71M
Barinthus Biotherapeutics 334.00K
Revenue Rankings